Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration

  • Post author:
  • Post category:

The leading cause of visual loss in Americans over the age of 65 is age related macular degeneration (AMD) which occurs in both a "wet" and a "dry" form. Both…

Continue ReadingAutologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration

Therapeutic potential of Retinal Pigment Epithelial cell lines derived from hES cells for retinal degeneration.

  • Post author:
  • Post category:

Retinal degeneration represents a group of blinding diseases that are increasingly impacting the health and well being of Californians. It is estimated that by 2020, over 450,000 Californians will suffer…

Continue ReadingTherapeutic potential of Retinal Pigment Epithelial cell lines derived from hES cells for retinal degeneration.

Developing gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models

  • Post author:
  • Post category:

Research Objective We will develop a gene therapy for a major inherited optic nerve disease and test the effectiveness of the treatment by analyzing healthy and patient stem cell-derived mini…

Continue ReadingDeveloping gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models